Establishment of a high-throughput detection system for DNA demethylating agents
Epigenetic alterations underlie various human disorders, including cancer, and this has resulted in the development of drugs targeting epigenetic alterations. Although DNA demethylating agents are one of the major epigenetic drugs, only two compounds—5-azacytidine (5-aza-CR, azacitidine) and 5-aza-2...
Main Authors: | Eriko Okochi-Takada, Naoko Hattori, Akihiro Ito, Tohru Niwa, Mika Wakabayashi, Kana Kimura, Minoru Yoshida, Toshikazu Ushijima |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-02-01
|
Series: | Epigenetics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15592294.2016.1267887 |
Similar Items
-
Active DNA demethylation—The epigenetic gatekeeper of development, immunity, and cancer
by: Rahul Prasad, et al.
Published: (2021-03-01) -
Targeting DNA methylation and demethylation in diabetic foot ulcers
by: Jun-Yu Deng, et al.
Published: (2023-12-01) -
Therapeutic Applications of Azanucleoside Analogs as DNA Demethylating Agents
by: Fallon Gallimore, et al.
Published: (2023-07-01) -
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
by: Kazunori Kawasoe, et al.
Published: (2023-10-01) -
Ten-eleven translocation proteins and their role beyond DNA demethylation – what we can learn from the fly
by: Joy N. Ismail, et al.
Published: (2020-11-01)